Mike Moradi

Mike Moradi is the Co-Founder and Chief Executive Officer of Sensulin, LLC, a biotechnology enterprise based in Oklahoma City, Oklahoma. Over the course of his career, he has co-founded or served as a principal executive in more than 14 life sciences and technology startups, including his foundational role at the publicly traded oral vaccine developer Vaxart. He previously operated as a Venture Partner at Artisan Healthcare Consulting and was selected as a Young Global Leader by the World Economic Forum. Moradi earned a degree in biochemistry from the University of Oklahoma and has successfully secured over $50 million in early-stage venture capital and federal grant funding from institutions like the National Institutes of Health. His current professional focus remains strictly centered on advancing novel glucose-responsive therapeutics and scaling biopharmaceutical ventures from initial discovery through clinical development.